Taken together, our study highlights the significance of DDX39B in the liver metastases and clinical outcome of CRC patients and reveal a novel mechanism by which DDX39B accelerates the nuclear translocation of PKM2 independent on ERK1/2-mediated phosphorylation of PKM2. This evidence concerns the gene DDX39B and colorectal carcinoma.